Expression of CCR2 by Endothelial Cells: Implications for MCP-1 Mediated Wound Injury Repair and In Vivo Inflammatory Activation of Endothelium
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Abstract—Endothelial cell proliferation and migration may play a central role in angiogenesis, wound healing, and atherosclerosis. Although CXC chemokines can act on endothelial cells by influencing proliferation, an involvement of CC chemokines and endothelial expression of chemokine receptors remains to be elucidated. Reverse transcription-polymerase chain reaction, RNase protection, Western blot, and flow cytometric analysis showed that human umbilical vein endothelial cells express mRNA and surface protein of the monocyte chemotactic protein-1 (MCP-1) receptor CCR2, which was upregulated by inflammatory cytokines. MCP-1 induced migration of endothelial cells in a transwell assay, which was inhibited by the 9-76 MCP-1 receptor antagonist. Increased secretion of MCP-1 or interleukin-8, but not RANTES, on endothelial injury suggested a functional role of CCR2 in wound repair as measured by ELISA. After mechanical injury to endothelial monolayers, which spontaneously closed within 24 hours, wound repair was delayed by the 9-76 antagonist and by a blocking monoclonal antibody to MCP-1, but not to interleukin-8, and was improved by exogenous MCP-1. This was confirmed by quantification of cell migration into the wound area, whereas proliferation and viability were unaltered by MCP-1 or its analogue. Notably, immunohistochemistry of inflamed tissue revealed CCR2 staining on arterial, venous, and venular endothelium affected by cellular infiltration. This is the first demonstration of endothelial CCR2 expression ex vivo, inferring its involvement in inflammatory conditions. Thus endothelial cells express functional CCR2 that may have important implications for endothelial wound repair and inflammatory reactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,226
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Monocyte chemoattractant protein-1 in human atheromatous plaques.
Nelken, N. A., Coughlin, S. R., Gordon, D., & Wilcox, J. N. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115411 · Cited by 880
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Cited by
Chemokines in cutaneous wound healing
Gillitzer, R., & Goebeler, M. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.513 · Cited by 943
“[66]”
The radiotherapeutic injury – a complex ‘wound’
Denham, J. W., & Hauer-Jensen, M. (2002) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(02)00060-9 · Cited by 596
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Soria, G., & Ben-Baruch, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.018 · Cited by 593
Wetzler, C., Kämpfer, H., Stallmeyer, B., Pfeilschifter, J., & Frank, S. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00029.x · Cited by 584
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Lim, S. Y., Yuzhalin, A. E., Gordon-Weeks, A. N., & Muschel, R. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7376 · Cited by 501
MCP-1: Chemoattractant with a role beyond immunity: A review
Yadav, A., Saini, V., & Arora, S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.006 · Cited by 488
Leukocyte extravasation: chemokine transport and presentation by the endothelium
Middleton, J., Patterson, A. M., Gardner, L., Schmutz, C., & Ashton, B. A. (2002) · Blood · doi:10.1182/blood.v100.12.3853 · Cited by 456
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Xu, M., Wang, Y., Xia, R., Wei, Y., & Wei, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13115 · Cited by 382
Stamatovic, S. M., Keep, R. F., Kunkel, S. L., & Andjelkovic, A. V. (2003) · Journal of Cell Science · doi:10.1242/jcs.00755 · Cited by 381
Hong, K. H., Ryu, J., & Han, K. H. (2005) · Blood · doi:10.1182/blood-2004-08-3178 · Cited by 382
Chemokines in tumor progression and metastasis
Sarvaiya, P. J., Guo, D., Ulasov, I., Gabikian, P., & Lesniak, M. S. (2013) · Oncotarget · doi:10.18632/oncotarget.1426 · Cited by 348
SALCEDO, R., & OPPENHEIM, J. J. (2003) · Microcirculation · doi:10.1038/sj.mn.7800200 · Cited by 328
Galkowska, H., Wojewodzka, U., & Olszewski, W. L. (2006) · Wound Repair and Regeneration · doi:10.1111/j.1743-6109.2006.00155.x · Cited by 317
CCL2/CCR2 signaling in cancer pathogenesis
Hao, Q., Vadgama, J. V., & Wang, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00589-8 · Cited by 315
Wound Healing in MIP-1α−/− and MCP-1−/− Mice
Low, Q. E. H., Drugea, I. A., Duffner, L. A., Quinn, D. G., Cook, D. N., Rollins, B. J., Kovacs, E. J., & DiPietro, L. A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61717-8 · Cited by 300
White, G. E., Iqbal, A. J., & Greaves, D. R. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005074 · Cited by 289
Postischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications
Silvestre, J.-S., Smadja, D. M., & Lévy, B. I. (2013) · Physiological Reviews · doi:10.1152/physrev.00006.2013 · Cited by 255
Macrophages: A review of their role in wound healing and their therapeutic use
Snyder, R. J., Lantis, J., Kirsner, R. S., Shah, V., Molyneaux, M., & Carter, M. J. (2016) · Wound Repair and Regeneration · doi:10.1111/wrr.12444 · Cited by 245
Hammond, M. D., Taylor, R. A., Mullen, M. T., Ai, Y., Aguila, H. L., Mack, M., Kasner, S. E., McCullough, L. D., & Sansing, L. H. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4070-13.2014 · Cited by 226
Chemokines as mediators of neovascularization
Keeley, E. C., Mehrad, B., & Strieter, R. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.162925 · Cited by 192
Pahler, J. C., Tazzyman, S., Erez, N., Chen, Y.-Y., Murdoch, C., Nozawa, H., Lewis, C. E., & Hanahan, D. (2008) · Neoplasia · doi:10.1593/neo.07871 · Cited by 184
Soria, G., Yaal-Hahoshen, N., Azenshtein, E., Shina, S., Leider-Trejo, L., Ryvo, L., Cohen-Hillel, E., Shtabsky, A., Ehrlich, M., Meshel, T., et al. (2008) · Cytokine · doi:10.1016/j.cyto.2008.08.002 · Cited by 92
Metadata
- Authors
- Weber, K. S. C., Nelson, P. J., Gröne, H.-J., & Weber, C.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1999-09
- Volume
- 19
- Issue
- 9
- Pages
- 2085-2093
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2111194166
- Cited by
- 279
- References
- 43
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.